197 related articles for article (PubMed ID: 22048586)
1. Application of Botulinum toxin type A: an arsenal in dentistry.
Rao LB; Sangur R; Pradeep S
Indian J Dent Res; 2011; 22(3):440-5. PubMed ID: 22048586
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of botulinum toxin in the treatment of temporomandibular disorders.
Song PC; Schwartz J; Blitzer A
Oral Dis; 2007 May; 13(3):253-60. PubMed ID: 17448205
[TBL] [Abstract][Full Text] [Related]
3. Type A botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction.
von Lindern JJ
Acta Neurol Belg; 2001 Mar; 101(1):39-41. PubMed ID: 11379274
[TBL] [Abstract][Full Text] [Related]
4. A review of the current uses of Botox for dentally-related procedures.
Bhogal PS; Hutton A; Monaghan A
Dent Update; 2006 Apr; 33(3):165-8. PubMed ID: 16700273
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
Ihde SK; Konstantinovic VS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
[TBL] [Abstract][Full Text] [Related]
6. Botulism toxin: use in disorders of the temporomandibular joint.
Chang H
Dent Today; 2005 Dec; 24(12):48, 50-1; quiz 51. PubMed ID: 16396158
[No Abstract] [Full Text] [Related]
7. Management of oromandibular dystonia.
Wessberg G
Hawaii Dent J; 2003; 34(6):15-6. PubMed ID: 14964082
[No Abstract] [Full Text] [Related]
8. Botulinum toxins in dentistry--the new paradigm for masticatory muscle hypertonicity.
Katz H
Singapore Dent J; 2005 Dec; 27(1):7-12. PubMed ID: 16438262
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin for the treatment of temporomandibular joint disk disfigurement: clinical experience.
Karacalar A; Yilmaz N; Bilgici A; Baş B; Akan H
J Craniofac Surg; 2005 May; 16(3):476-81. PubMed ID: 15915120
[TBL] [Abstract][Full Text] [Related]
10. Use of botulinum toxin A for treatment of myofascial pain and dysfunction.
Fallah HM; Currimbhoy S
J Oral Maxillofac Surg; 2012 May; 70(5):1243-5. PubMed ID: 22538024
[No Abstract] [Full Text] [Related]
11. Osteopenic consequences of botulinum toxin injections in the masticatory muscles: a pilot study.
Raphael KG; Tadinada A; Bradshaw JM; Janal MN; Sirois DA; Chan KC; Lurie AG
J Oral Rehabil; 2014 Aug; 41(8):555-63. PubMed ID: 24836732
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin a injection of the obturator internus muscle for chronic perineal pain.
Gajraj NM
J Pain; 2005 May; 6(5):333-7. PubMed ID: 15890635
[TBL] [Abstract][Full Text] [Related]
13. Botox in the dental office--is it worth the risk?
Thomason R
Pa Dent J (Harrisb); 2007; 74(4):54-5. PubMed ID: 17874579
[No Abstract] [Full Text] [Related]
14. Clinical use of botulinum toxins in oral and maxillofacial surgery.
Majid OW
Int J Oral Maxillofac Surg; 2010 Mar; 39(3):197-207. PubMed ID: 19959337
[TBL] [Abstract][Full Text] [Related]
15. The Mechanism of the Beneficial Effect of Botulinum Toxin Type a Used in the Treatment of Temporomandibular Joints Dysfunction.
Malgorzata P; Piotr C; Edward K
Mini Rev Med Chem; 2017; 17(5):445-450. PubMed ID: 27151142
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular injection of botulinum toxin as an adjunct to total joint replacement in temporomandibular joint ankylosis: preliminary reports.
Robiony M
J Oral Maxillofac Surg; 2011 Jan; 69(1):280-4. PubMed ID: 21055863
[No Abstract] [Full Text] [Related]
17. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity.
von Lindern JJ; Niederhagen B; Bergé S; Appel T
J Oral Maxillofac Surg; 2003 Jul; 61(7):774-8. PubMed ID: 12856249
[TBL] [Abstract][Full Text] [Related]
18. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study.
Sidebottom AJ; Patel AA; Amin J
Br J Oral Maxillofac Surg; 2013 Apr; 51(3):199-205. PubMed ID: 22871559
[TBL] [Abstract][Full Text] [Related]
19. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
20. Measurement of occlusal forces in the therapy of functional disorders with the use of botulinum toxin type A.
Pihut M; Wisniewska G; Majewski P; Gronkiewicz K; Majewski S
J Physiol Pharmacol; 2009 Dec; 60 Suppl 8():113-6. PubMed ID: 20400803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
